Literature DB >> 23590204

Use of experimental design to optimize docking performance: the case of LiGenDock, the docking module of LiGen, a new de novo design program.

Claudia Beato1, Andrea R Beccari, Carlo Cavazzoni, Simone Lorenzi, Gabriele Costantino.   

Abstract

On route toward a novel de novo design program, called LiGen, we developed a docking program, LiGenDock, based on pharmacophore models of binding sites, including a non-enumerative docking algorithm. In this paper, we present the functionalities of LiGenDock and its accompanying module LiGenPocket, aimed at the binding site analysis and structure-based pharmacophore definition. We also report the optimization procedure we have carried out to improve the cognate docking and virtual screening performance of LiGenDock. In particular, we applied the design of experiments (DoE) methodology to screen the set of user-adjustable parameters to identify those having the largest influence on the accuracy of the results (which ensure the best performance in pose prediction and in virtual screening approaches) and then to choose their optimal values. The results are also compared with those obtained by two popular docking programs, namely, Glide and AutoDock for pose prediction, and Glide and DOCK6 for Virtual Screening.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23590204     DOI: 10.1021/ci400079k

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  6 in total

1.  Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen.

Authors:  Maria Kuzikov; Elisa Costanzi; Jeanette Reinshagen; Francesca Esposito; Laura Vangeel; Markus Wolf; Bernhard Ellinger; Carsten Claussen; Gerd Geisslinger; Angela Corona; Daniela Iaconis; Carmine Talarico; Candida Manelfi; Rolando Cannalire; Giulia Rossetti; Jonas Gossen; Simone Albani; Francesco Musiani; Katja Herzog; Yang Ye; Barbara Giabbai; Nicola Demitri; Dirk Jochmans; Steven De Jonghe; Jasper Rymenants; Vincenzo Summa; Enzo Tramontano; Andrea R Beccari; Pieter Leyssen; Paola Storici; Johan Neyts; Philip Gribbon; Andrea Zaliani
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11

2.  Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions.

Authors:  Laura Brandolini; Michele d'Angelo; Rubina Novelli; Vanessa Castelli; Cristina Giorgio; Anna Sirico; Pasquale Cocchiaro; Francesco D'Egidio; Elisabetta Benedetti; Claudia Cristiano; Antonella Bugatti; Anna Ruocco; Pier Giorgio Amendola; Carmine Talarico; Candida Manelfi; Daniela Iaconis; Andrea Beccari; Andreza U Quadros; Thiago M Cunha; Arnaldo Caruso; Roberto Russo; Annamaria Cimini; Andrea Aramini; Marcello Allegretti
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

3.  Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.

Authors:  Candida Manelfi; Jonas Gossen; Silvia Gervasoni; Carmine Talarico; Simone Albani; Benjamin Joseph Philipp; Francesco Musiani; Giulio Vistoli; Giulia Rossetti; Andrea Rosario Beccari; Alessandro Pedretti
Journal:  Molecules       Date:  2021-02-04       Impact factor: 4.411

4.  Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.

Authors:  Andrea R Beccari; Marica Gemei; Matteo Lo Monte; Nazareno Menegatti; Marco Fanton; Alessandro Pedretti; Silvia Bovolenta; Cinzia Nucci; Angela Molteni; Andrea Rossignoli; Laura Brandolini; Alessandro Taddei; Lorena Za; Chiara Liberati; Giulio Vistoli
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

5.  Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.

Authors:  Marica Gemei; Carmine Talarico; Laura Brandolini; Candida Manelfi; Lorena Za; Silvia Bovolenta; Chiara Liberati; Luigi Del Vecchio; Roberto Russo; Carmen Cerchia; Marcello Allegretti; Andrea Rosario Beccari
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

6.  A Review on Parallel Virtual Screening Softwares for High-Performance Computers.

Authors:  Natarajan Arul Murugan; Artur Podobas; Davide Gadioli; Emanuele Vitali; Gianluca Palermo; Stefano Markidis
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.